[1]曹显庚,常 雪,谢秀英,等.宫腔镜宫腔粘连切除后雌激素干预宫腔再粘连危险因素分析[J].陕西医学杂志,2022,51(11):1376-1380.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.013]
 CAO Xiangeng,CHANG Xue,XIE Xiuying,et al.Risk factors of intrauterine re-adhesion with estrogen intervention after hysteroscopic transcervical resection of adhesion[J].,2022,51(11):1376-1380.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.013]
点击复制

宫腔镜宫腔粘连切除后雌激素干预宫腔再粘连危险因素分析
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年11期
页码:
1376-1380
栏目:
临床研究
出版日期:
2022-11-05

文章信息/Info

Title:
Risk factors of intrauterine re-adhesion with estrogen intervention after hysteroscopic transcervical resection of adhesion
作者:
曹显庚1常 雪1谢秀英2杨 希1
(1.安康市妇幼保健院妇产科,陕西 安康 725000; 2.西安交通大学第二附属医院妇产科,陕西 西安710004)
Author(s):
CAO XiangengCHANG XueXIE XiuyingYANG Xi
(Department of Obstetrics and Gynecology,Ankang Maternal and Child Health Hospital,Ankang 725000,China)
关键词:
宫腔粘连 宫腔镜 宫腔粘连切除术 雌激素干预 宫腔再粘连 危险因素
Keywords:
Intrauterine adhesion Hysteroscope Transcervical resection of adhesion Estrogen intervention Intrauterine re-adhesion Risk factor
分类号:
R 713.4
DOI:
DOI:10.3969/j.issn.1000-7377.2022.11.013
文献标志码:
A
摘要:
目的:探讨宫腔镜宫腔粘连切除后雌激素干预宫腔再粘连的危险因素。方法:回顾性分析239例宫腔粘连患者的临床资料,所有患者均接受宫腔镜宫腔粘连切除术治疗,且术后予以雌激素干预治疗,根据患者术后1年内宫腔再粘连情况分为再粘连组(n=31)和非再粘连组(n=208)。收集两组患者一般资料,采用单因素及多因素Logistics回归模型分析影响宫腔粘连患者宫腔镜宫腔粘连切除后雌激素干预宫腔再粘连的危险因素。结果:239例接受宫腔镜宫腔粘连切除且予以雌激素干预治疗的患者中,31例发生宫腔再粘连,发生率为12.97%; 再粘连组与非再粘连组在病程、人工流产次数、粘连程度、粘连性质、宫腔操作次数、放置宫内节育器及雌激素用量等方面比较,差异有统计学意义(均P<0.05); 多因素Logistic回归模型分析结果显示,病程≥1年、人工流产次数>2次、重度粘连、肌性粘连、宫腔操作次数>2次、未放置宫内节育器、小剂量雌激素均为宫腔粘连患者宫腔镜宫腔粘连切除后雌激素干预宫腔再粘连的独立危险因素(均P<0.05); 雌激素大剂量组不良反应发生率为18.26%高于雌激素小剂量组的8.87%(P<0.05)。结论:病程≥1年、人工流产次数>2次、重度粘连、肌性粘连、宫腔操作次数>2次、未放置宫内节育器、小剂量雌激素是宫腔镜宫腔粘连切除后雌激素干预宫腔再粘连的危险因素,临床需重视上述危险因素并据此予以针对性措施,以期降低宫腔再粘连风险。
Abstract:
Objective:To explore the risk factors of intrauterine re-adhesion with estrogen intervention after hysteroscopic transcervical resection of adhesion(TCRA).Methods:A retrospective analysis was performed on the clinical data of 239 patients with intrauterine adhesion.All underwent hysteroscopic TCRA and then were given estrogen intervention.According to presence or absence of intrauterine re-adhesion within 1 year after surgery,they were divided into re-adhesion group(31 cases)and non-re-adhesion group(208 cases).General data in both groups were collected.Risk factors of intrauterine re-adhesion were analyzed by univariate analysis and multivariate Logistic regression analysis.Results:Among the 239 patients,there were 31 cases(12.97%)with intrauterine re-adhesion.The differences in disease course,times of induced abortion,adhesion degree,natures of adhesion,times of intrauterine operations,placement of intrauterine device and dosage of estrogen between two groups were statistically significant(all P<0.05).The results of multivariate Logistic regression analysis showed that disease course ≥1 year,times of induced abortion >twice,severe adhesion,muscular adhesion,times of intrauterine operations >twice,no placement of intrauterine device and low-dose estrogen were independent risk factors of intrauterine re-adhesion(all P<0.05).The incidence of adverse reactions in high-dose estrogen group was higher than that in low-dose estrogen group(18.26% vs. 8.87%,P<0.05).Conclusion:Disease course ≥1 year,times of induced abortion >twice,severe adhesion,muscular adhesion,times of intrauterine operations >twice,no placement of intrauterine device and low-dose estrogen are risk factors of intrauterine re-adhesion with estrogen intervention after hysteroscopic TCRA.Clinically,it is necessary to pay attentions to the above risk factors and take targeted measures accordingly in order to reduce the risk of intrauterine re-adhesion.

参考文献/References:

[1] 关艳杰.中重度宫腔粘连病因及治疗研究进展[J].陕西医学杂志,2020,49(2):254-256.
[2] 黄丽娜,何秀珍.经阴道三维超声检查对宫腔粘连的诊断价值及漏诊原因分析[J].陕西医学杂志,2021,50(4):421-424.
[3] 侯安丽,刘慧兰,周秀英.COOK球囊联合雌孕激素序贯治疗预防宫腔镜下宫腔粘连分离术后宫腔再粘连的临床效果观察[J].实用妇产科杂志,2019,35(8):601-604.
[4] 刘红珍,黄晓春,汪承秀.不同雌激素用药方案对中重度宫腔粘连患者宫腔镜术后粘连复发的影响[J].实用临床医药杂志,2020,24(15):105-107,122.
[5] 赵现立,南 燕,齐 进,等.中重度宫腔粘连宫腔镜电切术后两种方案预防再粘连临床研究[J].陕西医学杂志,2018,47(2):165-167,170.
[6] 沈海燕,胡林义,樊莉琳,等.宫腔粘连分离术后患者复发现状及其相关影响因素分析[J].中国妇产科临床杂志,2021,22(5):520-521.
[7] 中华医学会妇产科学分会.宫腔粘连临床诊疗中国专家共识[J].中华妇产科杂志,2015,50(12):881-887.
[8] Listed N.The American Fertility Society classifications of adnexal adhesions,distal tubal occlusion,tubal occlusion secondary to tubal ligation,tubal pregnancies,müllerian anomalies and intrauterine adhesions[J].Fertil Steril,1988,49(6):944-55.
[9] 毛利云,朱 铮,王屹雯,等.补肾填精行气活血法治疗中重度宫腔粘连疗效研究[J].陕西中医,2020,41(12):1731-1734.
[10] 李海霞,程艳芬,夏利花.宫腔镜下宫腔粘连松解手术治疗宫腔粘连的效果及危险因素分析[J].中国妇幼保健,2021,36(2):465-467.
[11] 牛红萍,詹兴秀,周晓娜,等.加味桃红四物汤联合芬吗通在宫腔粘连中的应用研究[J].陕西中医,2018,39(2):205-207.
[12] 张连民,吕晓亮,赵 旭.中重度宫腔粘连宫腔镜手术后预防再次粘连的三种方法疗效比较[J].腹腔镜外科杂志,2020,25(4):302-306.
[13] 闫志强,林丽慧,陈 真,等.宫腔镜下持续放置水囊联合大剂量雌激素对宫腔粘连分离术患者子宫内膜功能恢复的影响[J].临床和实验医学杂志,2021,20(4):424-427.
[14] Zhang L,Wang M,Zhang Q,et al.Estrogen therapy before hysteroscopic adhesiolysis improves the fertility outcome in patients with intrauterine adhesions[J].Arch Gynecol Obstet,2019,300(4):933-939.
[15] 王燕尔,曾艳梅,胡惠敏.宫腔粘连患者宫腔镜术后复发的危险因素分析[J].中国妇幼保健,2021,36(2):306-309.
[16] 周 朝.中重度宫腔粘连术后再粘连影响因素分析[J].中国妇幼保健,2021,36(9):2126-2128.
[17] 尤俊霞,钟细妹,黄 平.宫腔镜系统治疗宫腔粘连效果及影响因素分析[J].中国计划生育学杂志,2021,29(8):1582-1586.
[18] 袁小丽,刘月合,王春佟,等.宫腔镜下宫腔粘连电切术后再粘连发生的因素调查分析[J].现代生物医学进展,2020,20(17):3325-3328.
[19] 施佳艳.宫腔镜手术治疗宫腔粘连影响因素分析[J].中国现代手术学杂志,2018,22(4):291-294.
[20] 张 璐,任 健.宫腔粘连患者宫腔镜下宫腔粘连分离术术后复发的危险因素分析[J].中国性科学,2021,30(8):92-95.
[21] 党 祎,张明德,林 剑.宫腔粘连分离术联合不同剂量雌激素治疗宫腔粘连对临床疗效凝血指标及复发的影响[J].中国药物与临床,2020,20(3):384-386.
[22] 刘 鑫.不同剂量雌激素联合阿司匹林用于二次宫腔镜宫腔粘连分离术后效果观察[J].人民军医,2021,64(12):1268-1270.

相似文献/References:

[1]何 巍,宋伟夫,张秋月,等.宫腔镜下冷刀分离术对宫腔粘连患者宫腔形态恢复及妊娠结局的影响[J].陕西医学杂志,2023,52(8):982.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.009]
 HE Wei,SONG Weifu,ZHANG Qiuyue,et al.Effect of hysteroscopic cold knife separation on recovery of uterine cavity morphology and pregnancy outcome in patients with uterine cavity adhesion[J].,2023,52(11):982.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.009]

备注/Memo

备注/Memo:
基金项目:陕西省社会发展科技攻关项目(2016SF-030); 西安市科技计划项目(20YXYJ0005-3)
更新日期/Last Update: 2022-11-09